Cargando…

Short-Term Treatment with Empagliflozin Resulted in Dehydration and Cardiac Arrest in an Elderly Patient with Specific Complications: A Case Report and Literature Review

Empagliflozin is a sodium-glucose cotransporter-2 inhibitor widely used in the treatment of diabetes mellitus and heart failure. Our case study involved a 68-year-old patient who was admitted to the hospital because of a cerebral infarction. The patient was simultaneously diagnosed with diabetes mel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Supakul, Sopak, Nishikawa, Yurika, Teramura, Masanori, Takase, Tetsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227880/ https://www.ncbi.nlm.nih.gov/pubmed/35744078 http://dx.doi.org/10.3390/medicina58060815

Ejemplares similares

A Call for Enhanced Healthcare Support for Increasingly Vulnerable Groups of Foreigners in Japan: Insights from a Former Thai-Native Medical Student in Japan
por: Supakul, Sopak, et al.
Publicado: (2021)

Utilization of Human Induced Pluripotent Stem Cells-Derived In vitro Models for the Future Study of Sex Differences in Alzheimer’s Disease
por: Supakul, Sopak, et al.
Publicado: (2021)

Severe Hypernatraemic Dehydration and Unconsciousness in a Care-Dependent Inpatient Treated with Empagliflozin
por: Gelbenegger, Georg, et al.
Publicado: (2017)

Access to Healthcare Services among Thai Immigrants in Japan: A Study of the Areas Surrounding Tokyo
por: Supakul, Sopak, et al.
Publicado: (2023)

The impact of dehydration on short-term postoperative complications in total knee arthroplasty
por: Lung, Brandon, et al.
Publicado: (2023)

Cardioprotective effects of short-term empagliflozin treatment in db/db mice
por: Radlinger, Bernhard, et al.
Publicado: (2020)

Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency
por: Supakul, Sopak, et al.
Publicado: (2020)

Empagliflozin: Novel antidiabetes and pro-cardiac drug
por: Raut, Monish S, et al.
Publicado: (2017)

Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs
por: Supakul, Sopak, et al.
Publicado: (2023)

Sodium–Glucose Co-Transporter 2 Inhibition With Empagliflozin Improves Cardiac Function After Cardiac Arrest in Rats by Enhancing Mitochondrial Energy Metabolism
por: Tan, Yunke, et al.
Publicado: (2021)

Imido-substituted triazines as dehydrative condensing reagents for the chemoselective formation of amides in the presence of free hydroxy groups
por: Kitamura, Masanori, et al.
Publicado: (2018)

The effect of mild dehydration on physical fitness of elderly individuals
por: Andrianopoulou, Maria-Vassiliki, et al.
Publicado: (2015)

Opiate Withdrawal Complicated by Tetany and Cardiac Arrest
por: Kugasia, Irfanali R., et al.
Publicado: (2014)

Out-of-hospital cardiac arrest complicated by hyperthermia
por: Edwards, Timothy, et al.
Publicado: (2022)

Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis
por: Refardt, Julie, et al.
Publicado: (2017)

Effect of high-fat diet and empagliflozin on cardiac proteins in mice
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells
por: Chen, Sha, et al.
Publicado: (2023)

Long‐Term Outcomes Among Elderly Survivors of Out‐of‐Hospital Cardiac Arrest
por: Chan, Paul S., et al.
Publicado: (2016)

Influence of the Level of Emergency Medical Facility on the Short-Term Treatment Results of Cardiac Arrest: Out-of-Hospital Cardiac Arrest and Interhospital Transfer
por: Chung, Je Young, et al.
Publicado: (2022)

Postop Complication With Euglycemic Diabetic Ketoacidosis in a Patient Receiving Empagliflozin
por: Fustiga, João, et al.
Publicado: (2022)

Comparison of complications secondary to cardiopulmonary resuscitation between out-of-hospital cardiac arrest and in-hospital cardiac arrest
por: Seung, M, et al.
Publicado: (2015)

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

Endosperm cellularization failure induces a dehydration-stress response leading to embryo arrest
por: Xu, Wenjia, et al.
Publicado: (2022)

Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats
por: Trang, Nguyen Ngoc, et al.
Publicado: (2021)

Pericytes as a Source of Osteogenic Cells in Bone Fracture Healing
por: Supakul, Sopak, et al.
Publicado: (2019)

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
por: Steven, Sebastian, et al.
Publicado: (2017)

ODP154 Reduction of Cardiac Adipose Tissue Volume with Short-Term Empagliflozin in Patients with Type 2 Diabetes: Results from the SIMPLE Randomized Clinical Trial
por: Brandt-Jacobsen, Niels, et al.
Publicado: (2022)

Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial
por: Brandt‐Jacobsen, Niels H., et al.
Publicado: (2023)

Long-term survival in patients presenting with STEMI complicated by out of hospital cardiac arrest
por: Samanta, Rahul, et al.
Publicado: (2018)

The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study
por: Chacko, Jithin, et al.
Publicado: (2021)

Admission Dehydration Status Portends Adverse Short-Term Mortality in Patients with Spontaneous Intracerebral Hemorrhage
por: Lehmann, Felix, et al.
Publicado: (2021)

Bradycardia, Hypotension, and Cardiac Arrest: A Complication of Local Anesthetics
por: Balasanmugam, Cynthia, et al.
Publicado: (2019)

Effects of Short-Duration Ethanol Dehydration on Mechanical Properties of Porcine Pericardium
por: Inoue, Tomoya, et al.
Publicado: (2020)

Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
por: Juni, Rio P., et al.
Publicado: (2019)

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
por: Hu, Zhaoyang, et al.
Publicado: (2021)

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
por: Puar, Pankaj, et al.
Publicado: (2023)

ECMO in Cardiac Arrest: A Narrative Review of the Literature
por: De Charrière, Amandine, et al.
Publicado: (2021)

Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient
por: Rathore, Azeem, et al.
Publicado: (2023)

Cardiac arrest in the elderly with silent myocardial ischemia during general anesthesia
por: Kim, Soon Yul, et al.
Publicado: (2013)

Effect of initial lactate level on short-term survival in patients with out-of-hospital cardiac arrest
por: Sarıaydın, Tuba, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cjtqet3itlcceqo8dp2kp0o9q9